Influence of mouthwashes on extended exhaled nitric oxide (FENO) analysis by Lassmann-Klee, PG et al.
Full Terms & Conditions of access and use can be found at
http://www.tandfonline.com/action/journalInformation?journalCode=iclb20
Scandinavian Journal of Clinical and Laboratory
Investigation
ISSN: 0036-5513 (Print) 1502-7686 (Online) Journal homepage: http://www.tandfonline.com/loi/iclb20
Influence of mouthwashes on extended exhaled
nitric oxide (FENO) analysis
Paul Guenther Lassmann-Klee, Lauri Lehtimäki, Tuula Lindholm, L. Pekka
Malmberg, Anssi Raimo Antero Sovijärvi & Päivi Piirilä
To cite this article: Paul Guenther Lassmann-Klee, Lauri Lehtimäki, Tuula Lindholm, L. Pekka
Malmberg, Anssi Raimo Antero Sovijärvi & Päivi Piirilä (2018) Influence of mouthwashes on
extended exhaled nitric oxide (FENO) analysis, Scandinavian Journal of Clinical and Laboratory
Investigation, 78:6, 450-455, DOI: 10.1080/00365513.2018.1497802
To link to this article:  https://doi.org/10.1080/00365513.2018.1497802
© 2018 Medisinsk Fysiologisk Forenings
Forlag (MFFF)
Published online: 22 Oct 2018.
Submit your article to this journal 
Article views: 126
View Crossmark data
ORIGINAL ARTICLE
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ABSTRACT
Fractional exhaled nitric oxide (FENO) is used to assess eosinophilic inflammation of the airways. FENO values
are influenced by the expiratory flow rate and orally produced NO. We measured FENO at four different expira-
tory flow levels after two different mouthwashes: tap water and carbonated water. Further, we compared the
alveolar NO concentration (CANO), maximum airway NO flux (J0awNO) and airway NO diffusion (DawNO) after
these two mouthwashes. FENO was measured in 30 volunteers (healthy or asthmatic) with a chemilumines-
cence NO-analyser at flow rates of 30, 50, 100 and 300mL/s. A mouthwash was performed before the meas-
urement at every flow rate. The carbonated water mouthwash significantly reduced FENO compared to the
tap water mouthwash at all expiratory flows: 50mL/s (p< .001), 30mL/s (p= .001), 100mL/s (p< .001) and
300mL/s (p= .004). J0awNO was also significantly reduced (p= .017), however, there were no significant differ-
ences in CANO and DawNO. In conclusion, a carbonated water mouthwash can significantly reduce oropharyn-
geal NO compared to a tap water mouthwash at expiratory flows of 30–300mL/s without affecting the CANO
and DawNO. Therefore, mouthwashes need to be taken into account when comparing FENO results.
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Introduction
Eosinophilic inflammation of the bronchial epithelium is a
chronic process often leading to bronchial hyperreactivity and
airway obstruction. During inflammation, fractional exhaled
nitric oxide (FENO) is mainly produced in the airway epithe-
lium, catalysed by inducible NO synthase (NOS2) [1]. In clin-
ical practice, assessing FENO facilitates asthma diagnosis [2].
FENO is a combination of nitric oxide (NO) originating
in the lung periphery, the bronchioli, the bronchi and the
central large airways, and FENO depends highly on the
expiratory flow rates. NO dynamics in the lung periphery
determine to a large extent FENO measured at higher flow
rates, while mainly bronchial NO dynamics determine FENO
measured at slower flow rates [3,4]. FENO measurement has
been previously recommended at the expiratory flow rate of
50mL/s [5,6]. There is evidence that FENO values over
50 ppb (>35 ppb in children) measured at this flow indicate
eosinophilic airway inflammation and the cut-off can be
applied to detect asthma in symptomatic individuals [7,8].
FENO measurement at multiple flows are used to estimate
the anatomical origin of NO in exhaled air [9–12]. A simple
two compartment model of the airways has been adopted
[6] to define the alveolar NO concentration (CANO), max-
imum airway NO flux (J0awNO) and airway NO diffusion
(DawNO) [13]. These estimates have provided extended infor-
mation in subjects with asthma [12–15].
In healthy subjects, a fraction of FENO seems to originate
in the upper airways and oropharynx, partly due to bacterial
production of NO and dietary intake of nitrate [16–21].
Rinsing the oral cavity with carbonated water lowers
FENO levels significantly in healthy and asthmatic subjects
[22,23]. Although the ATS/ERS guidelines suggest that a
mouthwash before FENO measurements may reduce oral
FENO, it is not part of the standardized clinical procedure
[5], but only recommended in physiological research [6].
However, rinsing of the mouth with carbonated water has
been routinely adopted in our laboratory at the Helsinki
University Hospital prior to FENO measurements since 1995.
The aim of this study was to compare the effects of a carbo-
nated water mouthwash and a tap water mouthwash on FENO at
different flow rates, as well to analyse the effects of the mouth-
washes on CANO, J0awNO and DawNO. Furthermore, we aimed to
investigate the repeatability of the FENO measurements.
Methods
We recruited 30 volunteers aged 16–68 years, either health-
care workers (n¼ 21) or patients (n¼ 9). The patients
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enrolled have had asthmatic symptoms and were previously
referred for FENO testing, either to the Laboratory of
Clinical Physiology at the University Hospital in Helsinki or
the Skin and Allergy Hospital in Helsinki. Healthcare work-
ers who volunteered were included without further selection.
None of the subjects were excluded. All participants were
asked to fill a questionnaire including questions regarding
smoking habits, asthma, allergic rhinitis and COPD.
Nine participants reported having allergic rhinitis, six
asthma and one COPD. Two participants smoked regularly,
one less than five cigarettes a day, the other from 5 to 15 a
day. From available medical records, we searched for
respiratory or systemic diseases that could influence FENO
values, reason for referral to FENO testing and current medi-
cation. Nine participants had a chronic respiratory disease
or respiratory symptoms. Among these were four patients
with asthma, three with respiratory symptoms due to build-
ing dampness but low or negative bronchial hyperreactivity,
one with eosinophilic bronchitis and another with Sj€ogren’s
syndrome. The patient with Sj€ogren’s syndrome had no
interstitial lung disease, previously ruled out through a high
resolution computed tomography. Six participants had pre-
scriptions for short acting beta2-agonists, four used inhaled
corticosteroids regularly, two used antihistamines and one
used leukotriene receptor antagonists. Spirometric data were
available in 25 subjects. None of these subjects had current
bronchodilator reversibility (defined as increase in FEV1 or
FVC over 12% and 200mL) [24]. Demographic, anthropo-
metric and spirometric data are summarised in Table 1.
The FENO measurements were made either at the Skin and
Allergy Hospital or at the Finnish Institute of Occupational
Health, both in Helsinki. The NO analysers used were chemi-
luminescence CLD 88 sp and the devices were
EXHALIZERVR ’s D with SPIROWAREVR software from Eco
Medics AG (D€urnten, Switzerland) and calibrated according to
the manufacturer’s instructions by using certified span gas
(AGA Gas BV, Amsterdam, Netherlands) and NO free air by
using a zero-air filter (DENOX 88 unit). The inspired gas was
NO free (<5ppb, maximum recorded fractional inspired Fino
was 3.1 ppb). Before the measurements, the ultrasonic flow
sensor was calibrated with a calibration syringe (Hans
Rudolph Inc., Shawnee, KS). FENO measurements for each sub-
ject were performed during two consecutive days. The flow-
chart in Figure 1 visualizes the order of the procedures. The
measurements were made at four different expiratory flow
rates V0 (30, 50, 100 and 300mL/s). The sequence of the flow
rates was kept the same, starting with a 50mL/s flow rate, fol-
lowed by 30, 100 and 300mL/s. The mouthwash procedure
was defined as rinsing the oral cavity for 30–60 seconds with
100mL of tap water or carbonated water. On the first day, the
subjects performed a mouthwash with tap water before the
measurements at the first flow level, and then repeated the
mouthwash with tap water before measuring at every flow
level. After reaching the highest flow level, i.e. 300mL/s, there
was a 15min pause before starting a new array. After this
time interval, all measurements were repeated, but 100mL of
carbonated water was used to perform the mouthwash.
During the second consecutive day, all tests were repeated in
the same fashion (i.e. two multiple-flow measurements of
FENO with different mouthwashes, totalling two arrays of test-
ing on each day). The mouthwashes were not randomized,
since the carbonated water mouthwash has a significantly lon-
ger effect on FENO than the tap water mouthwash [22].
A minimum of two measurements of FENO at each flow
were performed to obtain an acceptable value. The measure-
ments at each stage were accepted if its variation was no
more than 2 ppb. If more than two attempts were needed for
getting a valid measurement, the oral rinsing was repeated.
To further analyse the data, a mean value was obtained from
four single determinations (two obtained each day) for every
subject at each flow and mouthwash setting.
Table 1. Demographic, anthropometric and spirometric data of the study participants.
n Mean (SD) Range Spirometry n Mean (SD) Range
Age (years) 30 43 (14) 16–68 FVC (l) 25 4.1 (1.1) 2.65–6.69
Height (cm) 30 171 (8) 157–186 FVC (%a) 25 93 (16) 50–120
Weight (kg) 30 73 (15) 49–109 FEV1 (l) 25 3.3 (0.9) 2.06–5.36
Female/male 17/13 57%/43% FEV1 (%a) 25 93 (16) 50–117
Asthma 6 21% FEV1/FVC ratio 25 0.80 (0.1) 0.69–0.98
Allergic rhinitis 9 31% FEV1/FVC (%a) 25 98 (7) 88–125
Smoking 2 7%
COPD 1 3%
Data presented as mean (SD) or percentage of total case number.
aPercentage of predicted value (predicted according to Viljanen et al. [25]).
Figure 1. Flowchart illustrating the procedures, mouthwashes and repetitions performed during one day. Tap: tap water mouthwash, carbonated: carbonated
water mouthwash.
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The bottled carbonated water used for the mouthwash
was commercially available (HARTWALL VICHY
ORIGINALVR , Oy Hartwall Ab, Helsinki, Finland) and had a
declared pH of 5.7–5.9; the tap water used had a pH of 8.3.
More detailed information regarding the solutions can be
found under Lassmann-Klee et al. [22].
All recommendations according to ATS/ERS were fol-
lowed, except from the selection of a wide range of expira-
tory flows and using a mouthwash [5]. All subjects refrained
from smoking four hours, from drinking coffee two hours
and from eating and drinking one hour before the study.
Also strenuous exercising prior measuring was discouraged.
Ethical committee approval was received (99/13/03/00/
15) and we followed the ethical principles stated in the
Declaration of Helsinki [26].
Statistics
Analyses were performed using IBMVR SPSSVR statistics soft-
ware version 22 (Armonk, NY), RKWARDVR version 0.6.5
frontend and RSTUDIOVR version 1.1.383 frontend to the R
statistics language (THE R FOUNDATIONVR , Vienna,
Austria), and we partially used GRAPHPADVR PRISMVR ver-
sion 5.04 to obtain the graphs (La Jolla, CA). The compari-
son of FENO was made using a Wilcoxon test for paired
probes. We accepted a significance level of a¼ 0.05 as sig-
nificant. The mean (SD) was obtained for each subject from
four FENO measurements after each mouthwash at flows 30,
50, 100 and 300mL/s, respectively. The median and the
median absolute deviation (MAD) was calculated too [27].
To prove the accuracy of the measurements, we used the
coefficient of variation (cv), defined as the quotient of stand-
ard deviation (SD) and mean. We defined a total mean
value of cv< 10% as acceptable. CANO, J0awNO and DawNO
were calculated using a nonlinear logarithmic transform-
ation (we used starting estimated values of the quadratic T
transformation, a second order approximation) according to
Eckel et al. [11] using following equation:
log FENO ¼ log J'awNODawNO þ CANO
J 'awNO
DawNO
 DawNO
_V
 !
þ e (1)
CANO, J0awNO or DawNO were also calculated using the
H€ogman and Meril€ainen algorithm (HMA), with mean FENO
and mean V0 values for the flow rates: 30mL/s, 100mL/s
and 300mL/s [12]. Cases with negative values for CANO and
with failure of consistency check were not ruled out.
The comparison of CANO, J0awNO or DawNO between
mouthwashes was made using a Wilcoxon test for paired
probes. All target variables were not normally distributed
(Shapiro–Wilk’s test). The differences between cv were ana-
lysed with a Wilcoxon test when comparing mouthwashes.
A comparison of all calculated cv results was made with
Friedman’s two-way ANOVA.
Results
The results of FENO measurements at multiple flow levels
are listed in Table 2 and visualised in Figure 2. Individual
FENO values are visualised in Figure 3. FENO ranged between
4.4 and 221.6 ppb and the median was 14.94 (MAD: 6.76)
ppb at a flow rate of 50mL/s after rinsing with tap water.
The mouthwash with carbonated water reduced FENO sig-
nificantly compared to the tap water mouthwash at every
flow rate.
Table 2. Summarized results of FENO at every flow rate and mouthwash either with tap water or carbonated water.
FENO (ppb) Median MAD IQR p
a Mean (SD) Differenceb Mean cv
c
Flow 30mL/s, tap water 22.86 10.11 20.4 .001 39.21(57.04) –4.6% 8.6 (4.5)
Flow 30mL/s, carbonated water 20.11 9.49 20.7 37.40(59.28) 7.3 (5.0)
Flow 50mL/s, tap water 14.94 6.76 13.3 <.001 27.27(40.19) –6.4% 8.4 (6.2)
Flow 50mL/s, carbonated water 14.91 7.24 14.4 25.51(38.01) 6.6 (3.9)
Flow 100mL/s, tap water 9.03 3.91 8.8 <.001 15.41(21.58) –4.4% 7.0 (6.6)
Flow 100mL/s, carbonated water 8.15 3.68 8.7 14.74(21.72) 6.1 (4.0)
Flow 300mL/s, tap water 3.84 1.36 3.2 .004 6.03(7.29) –4.2% 6.9 (4.1)
Flow 300mL/s, carbonated water 3.53 1.31 3.0 5.77(7.45) 8.0 (5.3)
Data presented as median, median absolute deviation (MAD), interquantile range (IQR), n¼ 30. Mean cv calculated from indi-
vidual cv of FENO (consisting of at least four valid FENO results for each flow rate and mouthwash).
aWilcoxon’s signed ranks test.
bRelative decrease of the mean.
cPresented as mean (SD) in percent.
Figure 2. FENO measured at multiple expiratory flow levels after different
mouthwashes. Pairs compared with the Wilcoxon signed-rank test.
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The mean cv of FENO stayed under 10% for all flow levels.
Comparing the cv between tap water rinsing and carbonated
water rinsing, no significant difference was found at any
flow level (at 30mL/s p = .094; at 50mL/s p = .125; at
100mL/s p = .245; at 300mL/s p= .688). Analysing cv for all
flow levels and mouthwashes resulted in no differ-
ence (p= .202).
When comparing J0awNO between mouthwashes, the
median J0awNO for carbonated water was significantly lower
using both models. CANO and DawNO did not differ signifi-
cantly between both mouthwashes. These results are sum-
marized in Table 3.
The NO fraction of inspired gas was at all times below
20 ppb as recommended, having a mean value of 0.35 ppb
(SD 0.34) [5].
Discussion
Mouthwashes
We found a statistically significant difference in FENO
between mouthwashes at all expiratory flow levels. FENO was
statistically significantly lower after rinsing with carbonated
water compared to tap water at all expiratory flow levels.
This confirms previous studies in which carbonated water
was used to perform a mouthwash [22,23], and suggests
endorsement of a carbonated water mouthwash prior mul-
tiple-flow testing.
In the present study, the difference between mouth-
washes was ca. –5% at all flow levels. This decrease of
FENO between mouthwashes equals our previously
observed reduction. We demonstrated recently that both
carbonated water and tap water mouthwashes lower FENO
significantly compared with the baseline and observed an
immediate decrease of FENO after a carbonated water
mouthwash of –18% and of –13% after a tap water
mouthwash [22]. Additionally, Piiril€a et al. [23] found at
50mL/s a decrease from baseline (without mouthwash) of
ca. –10% after a carbonated water mouthwash in a healthy
population. In comparison, previous multiple flow studies
have found a relative decrease in FENO of ca. –10% after a
chlorhexidine mouthwash in children and adolescent (both
asthmatic and healthy) [28] and of ca. –15% in healthy
adults [29].
Furthermore, the tap water mouthwash’s effect is short-
lasting, only two minutes. On the other hand, the carbo-
nated water mouthwash’s effect is longer, lasting 12minutes,
and more effective if compared with tap water [22]. For this
0
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Figure 3. Individual FENO values measured at multiple expiratory flow levels after different mouthwashes. Ordinate represents the individuals (n¼ 30), abscissa rep-
resents FENO (ppb) at multiple expiratory flow levels after: carbonated water mouthwash (black dots), and tap water mouthwash (grey rhombi). Abscissa truncated
at 75 ppb. Subjects 1 and 2 had higher FENO (ppb) values (not shown). The missing higher values (tap water/carbonated) for subject 1 are: 128/128, 85/79; and for
subject 2 are: 311/322, 222/208, 117/117.
Table 3. Results of J0awNO, CANO and DawNO, after carbonated water or tap water mouthwash.
J0awNO (pL/s) p
a CANO (ppb) p
a DawNO (pLs–1ppb–1) pa
Tap water 836.36 (457.58) .015 0.88 (0.48) .715 14.19 (7.52) .299
Carbonated water 829.97 (443.12) 0.92 (0.33) 18.60 (3.87)
Tap waterb 796.88 (449.86) <.001 1.00 (0.39) .598 15.63 (6.95) .871
Carbonated waterb 724.96 (392.60) 1.04 (0.30) 15.28 (3.67)
Data presented as median (median absolute deviation), n¼ 30.
aWilcoxon’s signed ranks test.
bCalculated with H€ogman and Meril€ainen algorithm.
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reason, we did not randomize the subjects in the present
study and performed the measurements with tap water first.
Our data were accurately collected, since the intra-indi-
vidual cv of FENO stayed low and the mean cv below 10%.
We did not find a difference in cv between mouthwashes.
The cv at 100mL/s is similar to previously reported by
Ekroos et al. [30] for a healthy male population taking into
account a time period of maximal 24 hours.
Multiple flow FENO and mouthwashes
As we expected, J0awNO was significantly lower after the car-
bonated water mouthwash compared to the tap water
mouthwash. There was no statistically significant difference
between mouthwashes when analysing CANO and DawNO.
We verified this results with estimated values for J0awNO,
CANO and DawNO and two different models. This further
strengthens our result, that the carbonated water mouth-
wash affects the airway fraction (due to oral NO reduction)
and not the peripheral alveolar NO, neither the NO diffu-
sion. We could state the hypothesis that the carbonated
water rinsing provides more exact values (without oral con-
tamination) in general. Heijkenskj€old-Rentzhog et al. pub-
lished similar findings when analysing J0awNO and CANO
after a chlorhexidine mouthwash [28]. This is in contrast to
results by Malinovschi et al. [29] who found also a decrease
in CANO after a chlorhexidine mouthwash. Both used a
trumpet-shaped model with corrections for axial diffusion
(TMAD). Kerckx et al. [31] demonstrated that, when using
a model correcting for axial diffusion to estimate CANO in
asthmatic patients (unobstructed and well-managed), CANO
is normal, even when J0awNO is elevated. This has been con-
firmed also for patients with severe asthma and during
exacerbation [32].
For our purposes, we employed a two compartment
model of the lung [4], without considering axial diffusion
[9], and applied a robust mathematical model [11]. This
model was tested previously exactly at the same flow levels
by Eckel et al. and did not impose flow limitations unlike
other models [11]. We obtained also values using the HMA
(without axial diffusion) and the results between mouth-
washes were similar. Although results from models with and
without axial diffusion are not directly equivalent, an ana-
logy can be made between the main findings of differ-
ent studies.
The strength of our study was using different parameters
to examine the effect of the carbonated water mouthwash
and for that using two different mathematical models. Our
calculations with Equation (1) provided negative values for
CANO in five cases for tap water mouthwash and four cases
for carbonated water mouthwash, which were not excluded.
A similar amount of negative values were obtained with the
HMA. This has been a regular problem with other models
providing a greater proportion of negative concentration
values. We disregarded the importance of these data, since
the comparison of CANO between mouthwashes showed no
difference (even when replacing these values for zero). Our
extended analysis of J0awNO, CANO and DawNO found these
values comparable to previous results in a healthy popula-
tion [33]. All results for CANO were under 2.3 ppb and none
of the subjects had a medical condition associated with
interstitial lung disease, therefore we assume that the sub-
jects with measured FENO over 25 ppb (n¼ 7) had an ele-
vated airway production of NO.
Limitations and implications
We acknowledge the limitation of not randomizing the
order of the expiratory flows levels. However, the limitation
was imposed by the nature of the flow levels used, i.e. the
high flow representing an expiratory burden to the partici-
pants. Previous studies reported a decrease in FENO after
forced expirations [34–36]. We selected on purpose an
incremental flow order to avoid the high flow expiration
influencing the slower expiration manoeuvres.
The tap water used to compare the effect of carbonated
water had a pH value over 8. The tap water in European
countries has a pH of 6.5–9.5 units (Council Directive 98/
83/EC of 3 November 1998 on the quality of water intended
for human consumption) and this range also complies with
WHO guidelines. Many countries may have lower tap
water’s pH values than 8. This may enhance the tap water’s
effect on oral FENO and lower the differences between tap
water and carbonated water. Nevertheless, further studies
are needed to elucidate if the pH is the crucial factor of the
mouthwash solutions.
Carbonated water poses an ideal candidate for perform-
ing a mouthwash before multiple flow measuring. It elimi-
nates oral NO interference more effectively than tap water
and for a prolonged period of time. Our recent publication
[22] argues for the clinical application of a mouthwash
before FENO measurement. Here, we demonstrate it influen-
ces only the airway fraction of FENO, and using carbonated
water as a mouthwash, in a more pronounced way.
Probably one mouthwash procedure with carbonated water
may suffice when performing a routine multiple-flow inves-
tigation, but repetitions might be useful if exact values are
needed, e.g. in physiological research.
Conclusions
We conclude that a carbonated water mouthwash can sig-
nificantly reduce oropharyngeal NO compared to a tap
water mouthwash at expiratory flows of 30–300mL/s with-
out affecting the CANO nor the DawNO. We imply that a car-
bonated water mouthwash is suitable for routine multiple-
flow FENO-analysis and evidently useful in clinical research.
This study strengthens the view that mouthwash procedures
shall be taken into account when comparing FENO values.
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